Priorities for CMV vaccine development.

Highlights: [•] A January 2012 meeting addressed priorities for development of vaccines to prevent disease caused by cytomegalovirus (CMV). [•] CMV causes serious disease, including congenital CMV and life-threatening infections in immunocompromised patients. [•] Discussions identified appropriate target populations for vaccine use and appropriate endpoints for vaccine studies. [•] Participants at the meeting also made specific suggestions for further research that could facilitate CMV vaccine development. [ABSTRACT FROM AUTHOR]